LAVA Therapeutics NV (LVTX) — Defensive Interval Ratio
LAVA Therapeutics NV (LVTX) has a Defensive Interval Ratio of 0 days as of September 2025. Defensive assets of $0.00 (cash $-, short-term investments $0.00, receivables $-) cover 0 days of daily cash needs of $11.59K/day. See LVTX working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
LAVA Therapeutics NV Defensive Interval Ratio (2019–2024)
This chart shows how LAVA Therapeutics NV's Defensive Interval Ratio has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the ratio stands at 0 days, meaning defensive assets of $0.00 can fund 0 days of operations without new revenue. See LVTX equity financing ratio to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for LAVA Therapeutics NV (2019–2024)
The table below presents the year-by-year Defensive Interval Ratio for LAVA Therapeutics NV from 2019 to 2024, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see LAVA Therapeutics NV (LVTX) total market value.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 842 days | $41.56 Million | $49.33K/day | $- | $41.56 Million | ▼ -453 days |
| 2023 | 1296 days | $53.04 Million | $40.93K/day | $- | $51.34 Million | ▲ +701 days |
| 2022 | 595 days | $35.79 Million | $60.15K/day | $- | $32.53 Million | ▼ -803 days |
| 2021 | 1398 days | $43.07 Million | $30.82K/day | $- | $42.33 Million | ▲ +1341 days |
| 2020 | 57 days | $1.14 Million | $20.10K/day | $- | $0.00 | ▲ +39 days |
| 2019 | 18 days | $69.00K | $3.90K/day | $- | $0.00 | — |